Entrada Therapeutics, Inc. · NASDAQ:TRDA

TCG Crossover GP I, LLC reported a 5.00% stake in Entrada Therapeutics, Inc. (Schedule 13G)

Event Nov 19, 2025 · Filed Nov 25, 2025

TCG Crossover GP I, LLC reported a 5.00% stake in Entrada Therapeutics, Inc., 1,917,344 shares, as a passive investor on Nov 19, 2025. Filed Nov 25, 2025 (Schedule 13G).

Stake
5.00%
Shares
1,917,344
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
TCG Crossover GP I, LLC5.00%1,917,344
TCG Crossover Fund I, L.P.5.00%1,917,344
Chen Yu5.00%1,917,344

Source

View original at SEC

Related